ketorolac tromethamine has been researched along with Keratitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abary, M; Abd El Rehem, RT; El-Mofty, HM; El-Nabarawi, MA; Khafagy, MM; Lotfy, NM; Salah, M; Teaima, M | 1 |
| Khalifa, YM; Mifflin, MD | 1 |
| Apple, DJ; Holzer, MP; Kasper, TJ; Sandoval, HP; Solomon, KD; Vargas, LG; Vroman, DT | 3 |
| Gordon, YJ; Romanowski, EG | 1 |
| Guidera, AC; Luchs, JI; Udell, IJ | 1 |
7 other study(ies) available for ketorolac tromethamine and Keratitis
| Article | Year |
|---|---|
Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
Topics: Administration, Ophthalmic; Animals; Antifungal Agents; Biological Availability; Candida; Cornea; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Combinations; Drug Compounding; Drug Evaluation, Preclinical; Drug Liberation; Gels; Humans; Keratitis; Ketorolac Tromethamine; Liposomes; Male; Microbial Sensitivity Tests; Nanoparticles; Natamycin; Particle Size; Permeability; Polymers; Rabbits | 2019 |
Keratitis and corneal melt with ketorolac tromethamine after conductive keratoplasty.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Corneal Diseases; Electrocoagulation; Female; Humans; Keratitis; Ketorolac Tromethamine; Middle Aged; Prednisolone; Presbyopia | 2011 |
[Diffuse lamellar keratitis: prophylactic treatment with ketorolac tromethamine 0.5% in an animal model].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Keratitis; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Models, Animal; Ophthalmic Solutions; Rabbits; Surgical Flaps | 2002 |
Corneal flap complications in refractive surgery: Part 2: postoperative treatments of diffuse lamellar keratitis in an experimental animal model.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Corneal Stroma; Disease Models, Animal; Glucocorticoids; Keratitis; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Lipopolysaccharides; Nedocromil; Ofloxacin; Ophthalmic Solutions; Postoperative Complications; Prednisolone; Pseudomonas aeruginosa; Rabbits; Refractive Surgical Procedures; Surgical Flaps | 2003 |
Evaluation of preoperative and postoperative prophylactic regimens for prevention and treatment of diffuse lamellar keratitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Disease Models, Animal; Drug Evaluation, Preclinical; Glucocorticoids; Keratitis; Ketorolac Tromethamine; Lipopolysaccharides; Nedocromil; Postoperative Care; Prednisolone; Preoperative Care; Pseudomonas aeruginosa; Rabbits; Surgical Flaps | 2004 |
Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cidofovir; Corneal Stroma; Cytosine; Diclofenac; Drug Interactions; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Keratitis; Ketorolac Tromethamine; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Rabbits; Random Allocation; Virus Replication; Virus Shedding | 2001 |
Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Corneal Ulcer; Diclofenac; Female; Humans; Keratitis; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Rupture | 2001 |